Fusion Genomics Corporation
Fusion Genomics provides high-sensitivity, multiplexed genomic diagnostics that identify and genotype infectious pathogens to support clinical decision-making and public-health surveillance. The company offers the ONETest workflow combining proprietary DNA/RNA capture probes (Quantum Probes), library-prep reagents (UNIPrep/ONETest kit), next-generation sequencing on Illumina platforms, and FusionCloud analytics for strain-level and resistance marker reporting. The platform is positioned as a B2B diagnostic and surveillance solution for clinical laboratories, public health agencies, and research groups, with validated use in Canada and the EU. Fusion Genomics is advancing a pipeline of targeted tests (influenza, avian influenza eDNA, hepatitis C, HPV, MDR/XDR tuberculosis, sepsis, and blood screening) to scale multiplex pathogen detection across clinical and environmental applications.
Fusion Genomics Corporation
Fusion Genomics provides high-sensitivity, multiplexed genomic diagnostics that identify and genotype infectious pathogens to support clinical decision-making and public-health surveillance. The company offers the ONETest workflow combining proprietary DNA/RNA capture probes (Quantum Probes), library-prep reagents (UNIPrep/ONETest kit), next-generation sequencing on Illumina platforms, and FusionCloud analytics for strain-level and resistance marker reporting. The platform is positioned as a B2B diagnostic and surveillance solution for clinical laboratories, public health agencies, and research groups, with validated use in Canada and the EU. Fusion Genomics is advancing a pipeline of targeted tests (influenza, avian influenza eDNA, hepatitis C, HPV, MDR/XDR tuberculosis, sepsis, and blood screening) to scale multiplex pathogen detection across clinical and environmental applications.